About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Articles

Optimum Utilisation of Novel Antiplatelet Agents in Clinical Practice

Citation:

Interventional Cardiology Review 2014;9(3):164–7

Preventive Percutaneous Coronary Intervention in ST-elevation Myocardial Infarction – The Primacy of Randomised Trials

Citation:

Interventional Cardiology Review 2015;10(1):32–4

Percutaneous Coronary Intervention in Patients Who Have an Indication for Oral Anticoagulation – an Evidence-based Approach to Antithrombotic Therapy

Citation:

Interventional Cardiology Review 2015;10(1):16–21

The Emerging Role of PCSK9 Inhibitors in Preventive Cardiology

Citation:

European Cardiology Review 2014;9(2):65–70